Abstract

Obesity is a public health burden disturbing all body functions and reproductive hormones. As obesity increases among females, there will be a rising challenge to physicians in care from fertility problems. Evening primrose oil (EPR oil) contains essential fatty acids including omega-6 linoleic acid with strong anti-inflammatory activity. Since EPR oil has utility in alleviating dysmenorrhea, this study aimed to ascertain its modulatory effect on systemic inflammation, reproductive hormones and estrus cycle irregularity in female obese rats. Thirty-two female rats were distributed to 4 groups: (i) normal, (ii) dietary obese-control female rats, and (iii and iv) dietary obese female rats treated with EPR oil (5 or 10 g/kg). Rats were examined for estrus regularity by taking vaginal smears daily during the last 2 weeks of the experiment. Serum level of insulin, leptin, adiponectin, and inflammatory cytokines was measured. In addition, serum lipid profile, and liver enzyme activities were estimated. Adipose tissues were taken for histopathologic examination as well as determination of gene expression for leptin, leptin receptors, adiponectin, and visfatin. Obese rats exhibited significant weight gain (90.69 ± 8.9), irregular prolonged estrus cycles (83.33%), increased serum levels of insulin, leptin, prolactin and testosterone and decreased gonadotropin levels. EPR oil exhibited a curative effect on obesity-related irregularity in estrus cycle and ovarian pathology. The underlying molecular mechanism may be related to reduction of systemic inflammation, alleviating insulin resistance and modulation of adipokine expression. EPR oil may be considered as a promising therapeutic intervention against obesity-related female hormonal disturbances and estrus irregularity.

Highlights

  • Clinical observations have indicated a solid association between obesity and infertility in females [1]

  • Treatment with the large dose of Evening primrose oil (EPR oil) produced a significant reduction in the body weight gain vs. the obese control group (Figure 2A)

  • Our study demonstrated that treatment with EPR oil mitigated hyperleptinemia and corrected the serum luteinizing hormone (LH) and gonadotropin levels

Read more

Summary

Introduction

Clinical observations have indicated a solid association between obesity and infertility in females [1]. Obese women suffer from insulin and leptin resistance, inducing hyperandrogenemia, modulation of steroidogenesis and polycystic ovaries syndrome (PCOS) [2,3,4,5]. Obesity increases systemic inflammation and disturbs the reproductive functions via negative effects on the ovaries [2]. The levels of insulin, estrone, luteinizing hormone (LH), and androstenedione are known to increase. These hormonal changes deteriorates hypothalamic-pituitary-gonadal axis leading to different gynecological consequences [6]. Adipose tissue secretes a variety of molecules known as adipokines which regulate many functions. Some of the major adipokines released from adipose tissue are leptin, adiponectin, and visfatin. Adipokines are considered key players in regulating the reproductive function [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call